Parthenolide Augments the Chemosensitivity of Non-small-Cell Lung Cancer to Cisplatin via the PI3K/AKT Signaling Pathway

The mortality rate of non-small-cell lung cancer (NSCLC) remains high worldwide. Although cisplatin-based chemotherapy may greatly enhance patient prognosis, chemotherapy resistance remains an obstacle to curing patients with NSCLC. Therefore, overcoming drug resistance is the main route to successf...

Full description

Saved in:
Bibliographic Details
Published in:Front Cell Dev Biol
Main Authors: Wu, Li-Mei, Liao, Xiao-Zhong, Zhang, Yan, He, Zi-Rui, Nie, Shi-Qing, Ke, Bin, Shi, Lin, Zhao, Jian-Fu, Chen, Wen-Hui
Format: Artigo
Language:Inglês
Published: Frontiers Media S.A. 2021
Subjects:
Cell and Developmental Biology
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7892899/
https://ncbi.nlm.nih.gov/pubmed/33614623
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcell.2020.610097
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items